These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 24819592)
1. Dronabinol and chronic pain: importance of mechanistic considerations. de Vries M; van Rijckevorsel DC; Wilder-Smith OH; van Goor H Expert Opin Pharmacother; 2014 Aug; 15(11):1525-34. PubMed ID: 24819592 [TBL] [Abstract][Full Text] [Related]
2. Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability. de Vries M; Van Rijckevorsel DC; Vissers KC; Wilder-Smith OH; Van Goor H Br J Clin Pharmacol; 2016 Mar; 81(3):525-37. PubMed ID: 26505163 [TBL] [Abstract][Full Text] [Related]
3. Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity. Weizman L; Dayan L; Brill S; Nahman-Averbuch H; Hendler T; Jacob G; Sharon H Neurology; 2018 Oct; 91(14):e1285-e1294. PubMed ID: 30185448 [TBL] [Abstract][Full Text] [Related]
4. [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain]. Clermont-Gnamien S; Atlani S; Attal N; Le Mercier F; Guirimand F; Brasseur L Presse Med; 2002 Nov; 31(39 Pt 1):1840-5. PubMed ID: 12496714 [TBL] [Abstract][Full Text] [Related]
5. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study. de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H; Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917 [TBL] [Abstract][Full Text] [Related]
6. Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies. Cooper ZD; Abrams DI Am J Drug Alcohol Abuse; 2019; 45(6):580-595. PubMed ID: 31687845 [No Abstract] [Full Text] [Related]
7. Open-label, add-on study of tetrahydrocannabinol for chronic nonmalignant pain. Haroutiunian S; Rosen G; Shouval R; Davidson E J Pain Palliat Care Pharmacother; 2008; 22(3):213-7. PubMed ID: 19042851 [TBL] [Abstract][Full Text] [Related]
8. [Tetrahydrocannabinol for treatment of chronic pain]. Elsner F; Radbruch L; Sabatowski R Schmerz; 2001 Jun; 15(3):200-4. PubMed ID: 11810357 [TBL] [Abstract][Full Text] [Related]
9. Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain. Escudero-Lara A; Argerich J; Cabañero D; Maldonado R Elife; 2020 Jan; 9():. PubMed ID: 31931958 [TBL] [Abstract][Full Text] [Related]
10. Effect profile of paracetamol, Δ9-THC and promethazine using an evoked pain test battery in healthy subjects. van Amerongen G; Siebenga P; de Kam ML; Hay JL; Groeneveld GJ Eur J Pain; 2018 Aug; 22(7):1331-1342. PubMed ID: 29635857 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. Narang S; Gibson D; Wasan AD; Ross EL; Michna E; Nedeljkovic SS; Jamison RN J Pain; 2008 Mar; 9(3):254-64. PubMed ID: 18088560 [TBL] [Abstract][Full Text] [Related]
12. The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain. Issa MA; Narang S; Jamison RN; Michna E; Edwards RR; Penetar DM; Wasan AD Clin J Pain; 2014 Jun; 30(6):472-8. PubMed ID: 24281276 [TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial. Almog S; Aharon-Peretz J; Vulfsons S; Ogintz M; Abalia H; Lupo T; Hayon Y; Eisenberg E Eur J Pain; 2020 Sep; 24(8):1505-1516. PubMed ID: 32445190 [TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study. Eisenberg E; Ogintz M; Almog S J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):216-25. PubMed ID: 25118789 [TBL] [Abstract][Full Text] [Related]
15. Sex differences and the endocannabinoid system in pain. Blanton HL; Barnes RC; McHann MC; Bilbrey JA; Wilkerson JL; Guindon J Pharmacol Biochem Behav; 2021 Mar; 202():173107. PubMed ID: 33444598 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence. Babalonis S; Walsh SL Eur Neuropsychopharmacol; 2020 Jul; 36():206-216. PubMed ID: 32273144 [TBL] [Abstract][Full Text] [Related]
17. Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain. Campbell CM; Mun CJ; Hamilton KR; Bergeria CL; Huhn AS; Speed TJ; Vandrey R; Dunn KE Neuropsychopharmacology; 2023 Oct; 48(11):1630-1638. PubMed ID: 37202479 [TBL] [Abstract][Full Text] [Related]
18. [Use and effectiveness of dronabinol (delta9-tetrahydrocannabinol) in chronic pain]. Gauter B; Rukwied R; Konrad C Schmerz; 2004 Dec; 18 Suppl 2():S11-4. PubMed ID: 23570083 [No Abstract] [Full Text] [Related]
19. Dark Classics in Chemical Neuroscience: Δ Banister SD; Arnold JC; Connor M; Glass M; McGregor IS ACS Chem Neurosci; 2019 May; 10(5):2160-2175. PubMed ID: 30689342 [TBL] [Abstract][Full Text] [Related]
20. Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Schley M; Legler A; Skopp G; Schmelz M; Konrad C; Rukwied R Curr Med Res Opin; 2006 Jul; 22(7):1269-76. PubMed ID: 16834825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]